Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience. [electronic resource]
Producer: 20200309Description: 174-178 p. digitalISSN:- 1423-0232
- Academic Medical Centers
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- adverse effects
- Antineoplastic Agents, Immunological -- adverse effects
- Disease Progression
- Female
- Humans
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Staging
- North Carolina
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Progression-Free Survival
- Retrospective Studies
- Risk Factors
- Skin Neoplasms -- drug therapy
- Temozolomide -- adverse effects
- Time Factors
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.